Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

EFFERALDOL 650 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/EFFERALDOL 650 MG COMPRIMIDOS

Approved

STANDARD

EFFERALDOL 650 MG COMPRIMIDOS

Upsa S.A.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 16, 2022
Approval ID: e80b41e98a5e78ec
Company: Upsa S.A.S.
Type: Standard

Approval Details

Approval Id: e80b41e98a5e78ec
Drug Cima Aemps Name: EFFERALDOL 650 MG COMPRIMIDOS
Register Number: 86627
Holder Company Name: Upsa S.A.S.
Marketing Company Name: Newline Pharma S.L.U.
Authorization Date: 2022-03-16
Dosage Form: COMPRIMIDO
Dose: 650 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Upsa S.A.S.

Active Ingredients

PARACETAMOL

650 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 16, 2022

Approval ID

e80b41e98a5e78ec

Type

Standard

Back to CIMA-AEMPS Approvals